Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …

A brief historical background of the development of the theranostic approach in nuclear
medicine is given and seven theranostic pairs of radionuclides, namely 44g Sc/47 Sc, 64 …

Inert and stable radiolabeling of monoclonal antibodies (mAb), antibody fragments, or
antibody mimetics with radiometals is a prerequisite for immuno-PET. While radiolabeling is …

Abstract 155 Tb [t 1/2= 5.32 d, E γ= 87 keV (32%); 105 keV (25%)(IAEA, 2021) is a novel
promising radionuclide for theranostic applications in nuclear medicine. Its physical …

The solution chemistry of the hydrolytic, early-transition-metal ions Ti4+ and Sc3+ represents
a coordination chemistry challenge with important real-world implications, specifically in the …

The availability of novel radionuclides plays a fundamental role in the development of
personalized nuclear medicine. In particular, there is growing interest in pairs formed by two …

Background With recent advances in novel approaches to cancer therapy and imaging, the
application of theranostic techniques in personalised medicine has emerged as a very …

Theranostic strategies involve select radionuclides that allow diagnostic imaging and
tailored radionuclide therapy in the same patient. An example of a Food and Drug …

Introduction: 43Sc and 44gSc are both positron-emitting radioisotopes of scandium with
suitable half-lives and favorable positron energies for clinical positron emission tomography …

44Sc has favorable properties for cancer diagnosis using Positron Emission Tomography
(PET) making it a promising candidate for application in nuclear medicine. The …